I joined Mike Roth on the Villages Vitality podcast talking about multiple #myeloma and #AI in #cancer care #mmsm
youtube.com/watch?v=WuXnRR…
YouTube
English
Adeel Khan MD MPH MS
2.4K posts
Adeel Khan MD MPH MS
@khancology
Physician/Asst Professor/Director @UTSWcancer in hematology/oncology & public health focusing on #myeloma. Tweets my own opinions & retweets ≠ endorsement #mmsm
UT Southwestern, Dallas TX Katılım Mayıs 2012
792 Takip Edilen716 Takipçiler
I spoke about the evolving role of autologous stem cell transplants in #myeloma: for all or for some? @binaytara @binayshah It's worth pausing, even as #transplants decline, how limited the access is to them in so many parts of the world #disparities @utswcancer
English
A pleasure speaking to patients at this weekend's amyloidosis support group event at @UTSWMedCenter - @HadidiSamer, @ldandersonjr, @staasan_MD #amyloidsupportgroups
English
The irreversibility is the unfortunate part
Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽@Rfonsi1
@VincentRK @RahulBanerjeeMD @NCCN Despite so many good things happening in MM, the issue of PN has been minimized. And it has a major impact on QOL. The recent BENEFIt trial with SQ and weekly shows ~50% PN with ~25% being grade 3-4 (which is probably high). I will keep trying to get K...
English
Adeel Khan MD MPH MS retweetledi
We welcome Myeloma Experts Dr. Mohyuddin (@ManniMD1) and Dr. Khan (@khancology) to our show! We are so excited to have our listeners hear their incredible pearls of wisdom.
And better yet - next week will be part 2!
English
A big step forward for the pancreatic cancer field - congrats to all on the RASolute 302 trial!
Looking forward to hearing full daraxonrasib data.
As a myeloma doctor, a second "dara" drug will bring some confusion... but this is a huge step forward for patients with panc CA!
English
Adeel Khan MD MPH MS retweetledi
Happening on Friday!
🔗Register: hemehub.org/live-webinars
🔗Case submissions: hemehub.org/case-submission
@szusmani @khancology #MultipleMyeloma #PlasmaCellDisorders #Hematology #Oncology #MedicalEducation #PatientCare #Immunotherapy #CellTherapy #NovelTherapies #ClinicalTrials #HemeHub #HematologyEducation
@MSKCancerCenter @UTSWHemeOnc @MM_Hub @theMMRF @IMFmyeloma
HemeHub@HemeHub
📌Session Update 🩸Our Multiple Myeloma session, previously postponed, has now been scheduled for April 10th! Join us with Dr. Saad Z. Usmani (@szusmani) and Dr. Adeel Khan (@khancology) for patient case discussions on multiple myeloma and advances in novel therapies, immunotherapy, and cellular treatment strategies. 🔗Register: hemehub.org/live-webinars 🔗Case submissions: hemehub.org/case-submission #MultipleMyeloma #PlasmaCellDisorders #Hematology #Oncology #MedicalEducation #PatientCare #Immunotherapy #CellTherapy #NovelTherapies #ClinicalTrials #HemeHub #HematologyEducation @MSKCancerCenter @UTSWHemeOnc
English
Adeel Khan MD MPH MS retweetledi
As part of #MyelomaActionMonth, we’re highlighting toxicity management for bispecific antibodies in multiple myeloma.
Dr. Adeel Khan (@khancology) of UT Southwestern discusses key toxicities and practical strategies for safe use in relapsed/refractory disease.
🎥 Watch on #Vumedi:
tinyurl.com/37bzk477
#MMsm #HemeOnc #Bispecifics
English
Adeel Khan MD MPH MS retweetledi
Met with the legend Bob Kyle yesterday. He has been our mentor and inspiration.
@myelomaMD @MayoClinic
English
Global health security and WHO: Why U.S. withdrawal is dangerous kevinmd.com/2026/03/global… via @kevinmd
English
YouTube
English
One should wonder about - likely there was a reason that they received antibiotics
Robert Z. Orlowski@Myeloma_Doc
#Myeloma Paper of the Day: Broad-spectrum antibiotics prior to T-cell engagers associated w/ significantly inferior 1-year OS (60 vs 77%) & PFS (26 vs 53%) & higher relapse incidence; microbiota composition correlated w/ therapy response & toxicity: pubmed.ncbi.nlm.nih.gov/41791791/. #mmsm
English
Thanks for featuring our work, @Myeloma_Doc !
Robert Z. Orlowski@Myeloma_Doc
#Myeloma Paper of the Day: Real-world analysis of resuming bone-modifying agents in relapsed myeloma does not show improvement in long-term survival outcomes (median PFS 10.1 vs 9.2 months; OS 39.6 vs 51.5 months for deferred vs. BMA-received pts): pubmed.ncbi.nlm.nih.gov/41733330/. #mmsm
English
Adeel Khan MD MPH MS retweetledi
Check out recent publication. The Last Word: Academic Oncology at a Crossroads: Rebuilding a Sustainable Career Path @JNCCN @utswcancer @AimazAfrough @khancology #MedTwitter
A crisis we can no longer ignore
✅Academic oncology is losing its best and brightest. This isn't burnout—it's a broken system.
✅After a decade of training beyond medical school, talented oncologists are walking away. Not from lack of passion, but because "we layered on metrics, administrative burden, and unrealistic expectations until the foundation cracked."
➡️Our take? "The question isn't whether change is needed—the data make that undeniable. The question is whether we'll act decisively before we lose another generation."
✅We outline real solutions: protect research time, value quality over quantity, fix RVU-driven metrics that ignore case complexity, and support diverse career tracks.
➡️ jnccn.org/view/journals/…
@ASCO @ASH_hematology @ASCOTECAG @HemOncFellows @hem
English
“Why the brain lets early memories fade” Microglia may explain infantile amnesia apple.news/A4XoR3wYuSJioX…
English
Adeel Khan MD MPH MS retweetledi
🔬🩸Join us for post #ASH2025 updates as leading experts break down the most impactful clinical and scientific findings from the 67th ASH Annual Meeting.
Hear focused insights from Taha Bat, MD, Musa Yilmaz, MD, Ibrahim Ibrahim, MD, Elif Yilmaz, MD and Adeel Khan, MD, highlighting key data, emerging therapies and updates shaping current practice in benign and malignant hematology.
🖥Virtual Event
December 12, 2025 | 7:30–8:30AM CST
➡️ Register now: hemehub.org/live-events
➡️You can also submit your own cases for the upcoming sessions at: hemehub.org/case-submission
#ASH2025 #ASH25 #Hematology #BloodDisorders #BenignHematology #MalignantHematology #ClinicalInsights #MedicalEducation #HEMEHUB
English
Adeel Khan MD MPH MS retweetledi
Listen to the latest @ASCO #JCO Cancer Stories: The Art of Oncology episode "A Fight Bigger Than Myeloma” w/ host @MikkaelSekeres & @khancology who uses pt's multiple myeloma story to highlight civil liberties progress & the work still ahead.
🎧: brnw.ch/21wWO5E
#mmsm
English
Adeel Khan MD MPH MS retweetledi
As one of the principal academic beneficiaries of Dr. Brian Durie’s mentorship, guidance, and kindness I am heartbroken to hear of his passing.
His contributions to myeloma and oncology are without parallel. Charismatic, brilliant, dedicated, Dr. Durie has had a huge impact on generations of myeloma researchers worldwide.
He founded the @IMFmyeloma and led it for over 30 years. He founded the International Myeloma Working Group (IMWG) and led it for over 20 years. He developed the Durie Salmon Staging System, which to this day remains as a true staging system. Helped countless patients. Educated, trained, guided countless doctors from around the world. I could go on and on.
I pray for him and his family.
English
Pleased to have contributed my thoughts to this piece on AI in #Time magazine time.com/7321821/chatgp…
English